Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AIDS-associated lymphomas.

L D Kaplan1

  • 1University of California, San Francisco.

Infectious Disease Clinics of North America
|June 1, 1988
PubMed
Summary
This summary is machine-generated.

Patients with HIV infection face a high risk of developing non-Hodgkin's lymphoma, often presenting with advanced disease. Treatment outcomes are poor due to complications and low response rates, highlighting a critical need for better therapeutic strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis.

Bone marrow transplantation·2014
Same author

Spectral band passes for a high precision satellite sounder.

Applied optics·2010
Same author

Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998
Same author

Clinical management of human immunodeficiency virus-associated non-Hodgkin's lymphoma.

Journal of the National Cancer Institute. Monographs·1998
Same author

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Area of Science:

  • Oncology
  • Infectious Diseases
  • Immunology

Background:

  • Patients with Human Immunodeficiency Virus (HIV) infection and organ transplant recipients share an increased risk for developing non-Hodgkin's lymphoma (NHL).
  • NHL in HIV-infected individuals typically presents as high-grade B-cell lymphomas, frequently with advanced extralymphatic involvement, including the central nervous system.
  • The etiology of AIDS-associated lymphomas remains incompletely understood, with Epstein-Barr virus DNA detected in only a subset of cases, unlike in transplant recipients.

Purpose of the Study:

  • To review the clinical characteristics, treatment challenges, and outcomes of non-Hodgkin's lymphoma in patients with HIV infection.
  • To discuss the prognostic factors influencing response and survival in this patient population.
  • To differentiate the presentation and prognosis of Hodgkin's disease in HIV-infected individuals.

Related Experiment Videos

Main Methods:

  • Review of existing literature and clinical data on non-Hodgkin's lymphoma in HIV-infected patients.
  • Analysis of treatment response rates, complications, and survival data.
  • Epidemiological assessment of Hodgkin's disease in the context of HIV infection.

Main Results:

  • Treatment response rates to chemotherapy are lower in HIV-associated lymphomas compared to other lymphoma patient groups.
  • Therapeutic challenges include limited bone marrow reserve and frequent opportunistic infections, leading to short survival times.
  • Good performance status and the absence of a prior Acquired Immunodeficiency Syndrome (AIDS) diagnosis are key predictors of better outcomes.
  • Hodgkin's disease in HIV-infected patients typically presents with poor prognostic features and advanced stage, resulting in median survivals under one year.

Conclusions:

  • Non-Hodgkin's lymphoma in HIV-infected patients presents significant therapeutic challenges with disappointing outcomes.
  • Prognosis is strongly influenced by patient performance status and prior AIDS diagnosis.
  • While Hodgkin's disease occurs in HIV-infected individuals, current data do not suggest a direct causal link, but it carries a poor prognosis.